Microsoft Research and Providence have developed TRIALSCOPE, an AI-powered framework that simulates and validates clinical trial outcomes using real-world patient data. Created after a three-year study of deidentified cancer data, it enables researchers to reproduce historical trial results, reduce early risk, and optimize trial planning, potentially shortening the long process of bringing new treatments to patients.
Replicating Clinical Trial Results Through AI: Providence and Microsoft See Possibilities Through Revolutionary New Tool
Share: